Yang Y, Fang C, Jiang Z, Su X, et al. Safety and efficacy of omalizumab in children aged 6 to 11 years with asthma: a systematic review and meta-analysis of randomized controlled trials. BMC Pediatr 2026 Feb 7. doi: 10.1186/s12887-026-06595.
PMID: 41652440